Latest1 information on COVID-19
©2022 Stanford Medicine
Viral & Host Factors Associated With Hepatitis B Virus-related Hepatocellular Carcinoma
Not Recruiting
Trial ID: NCT00767936
Purpose
Adult liver cancer is the third leading cause of cancer deaths worldwide. The major risk
factor for liver cancer is hepatitis B virus (HBV) infection. The purpose of the study is to
sequence the HBV genome in patients with chronic HBV infection, and in patients with liver
cancer resulting from chronic HBV infection. The goal is to identify mutations in the HBV
genome that predisposes these high risk individuals to the development of liver cancer.
Official Title
Viral and Host Factors Associated With Development of Hepatitis B Virus-related Hepatocellular Carcinoma
Stanford Investigator(s)
Samuel So, MD
Lui Hac Minh Professor in the School of Medicine
Eligibility
Inclusion Criteria:1. Patients diagnosed with liver cancer based on biopsy or serum AFP
level, associated with characteristic hypervascular liver tumors on triphasic spiral CT
scan or MRI.
2. Patients with non-cancer liver conditions such as cirrhosis, adenoma, cholangioma, or
nodular hyperplasia.
3. Patients with hepatitis B or hepatitis C viral infections not associated with liver
cancer. Exclusion Criteria:No other patients except those listed above will be recruited.
Additionally, patients will be excluded if, upon looking through their medical records,
information required for data analysis are missing.
Not Recruiting
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
ccto-office@stanford.edu
650-498-7061